0002059988-25-000001.txt : 20250508 0002059988-25-000001.hdr.sgml : 20250508 20250508102058 ACCESSION NUMBER: 0002059988-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250508 DATE AS OF CHANGE: 20250508 EFFECTIVENESS DATE: 20250508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stork Therapeutics, Inc. CENTRAL INDEX KEY: 0002059988 ORGANIZATION NAME: EIN: 992268848 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-545504 FILM NUMBER: 25924500 BUSINESS ADDRESS: STREET 1: 325 15TH AVENUE CITY: SAN FRANCISCO STATE: CA ZIP: 94118 BUSINESS PHONE: (415) 699-7583 MAIL ADDRESS: STREET 1: 325 15TH AVENUE CITY: SAN FRANCISCO STATE: CA ZIP: 94118 D 1 primary_doc.xml X0708 D LIVE 0002059988 Stork Therapeutics, Inc. 325 15TH AVENUE SAN FRANCISCO CA CALIFORNIA 94118 (415) 699-7583 DELAWARE None None Corporation true 2024 Gregg Fine c/o Stork Therapeutics, Inc. 325 15th Avenue San Francisco CA CALIFORNIA 94118 Executive Officer Director Promoter Brendan Kennedy c/o Stork Therapeutics, Inc. 325 15th Avenue San Francisco CA CALIFORNIA 94118 Director Biotechnology Decline to Disclose 06b false 2025-04-24 false true false 0 2725000 1345000 1380000 false 3 0 0 0 false Stork Therapeutics, Inc. /s/ Gregg Stork Gregg Stork Chief Executive Officer 2025-05-08